CAMP - CAMP4 Therapeutics Corporation Stock Analysis | Stock Taper
Logo

About CAMP4 Therapeutics Corporation

https://www.camp4tx.com

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Joshua Mandel-Brehm

CEO

Joshua Mandel-Brehm

Compensation Summary
(Year 2024)

Salary $557,250
Option Awards $404,991
Incentive Plan Pay $201,000
All Other Compensation $1,131,744
Total Compensation $2,294,985
Industry Biotechnology
Sector Healthcare
Went public October 11, 2024
Method of going public IPO
Full time employees 55

Split Record

Date Type Ratio
1996-03-25 Forward 2:1

ETFs Holding This Stock

Ratings Snapshot

Rating : C+

Discounted Cash Flow 3
Return On Equity 1
Return On Assets 1
Debt To Equity 3
Price To Earnings 1
Price To Book 4
Overall Score 2

Most Recent Analyst Grades

Grade Summary

Overweight 1
Neutral 1

Showing Top 2 of 2

Price Target

Target High $7
Target Low $7
Target Median $7
Target Consensus $7

Institutional Ownership